Inventor · disambiguated record
Shigekazu Sasaki
Also filed as: SASAKI SHIGEKAZU
16 granted patents·8 pending applications·28 citations·filing 2003–2025
90Inventor score
Files withTAKEDA PHARMACEUTICALS CO10UNIV NAT CORP TOKYO MEDICAL & DENTAL5SASAKI SHIGEKAZU4TAKEDA PHARMACEUTICAL2FENG JUN1
Top patents by PatentIndex Score
24 records- 0191US10214498B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Feb 26, 2019·4 cites·12 claims
- 0289US10544111B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jan 28, 2020·3 cites·41 claims
- 0383US10975043B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Apr 13, 2021·1 cites·2 claims
- 0475US9975903B2Condensed heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted May 22, 2018·2 cites·11 claims
- 0575US8314088B2Pyrazinooxazepine derivativesSASAKI SHIGEKAZU·Filed 2011·Granted Nov 20, 2012·2 cites·2 claims
- 0674US9115139B2Pyrazinooxazepine derivativesSASAKI SHIGEKAZU·Filed 2010·Granted Aug 25, 2015·2 cites·6 claims
- 0774US8318722B2Pyrazinooxazepine derivativesSASAKI SHIGEKAZU·Filed 2010·Granted Nov 27, 2012·2 cites·2 claims
- 0873US7553867B2Furan or thiophene derivative and medicinal use thereofTAKEDA PHARMACEUTICAL·Filed 2003·Granted Jun 30, 2009·9 cites·27 claims
- 0970US8324201B2Pyrazinooxazepine derivativesSASAKI SHIGEKAZU·Filed 2011·Granted Dec 4, 2012·1 cites·2 claims
- 1070US2021340114A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1169US9469637B2Nitrogenated heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Oct 18, 2016·1 cites·2 claims
- 1269US2023295628A1Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2023·Application pending·0 cites
- 1368US9556200B2Tricyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Jan 31, 2017·1 cites·8 claims
- 1465US11597928B2Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted Mar 7, 2023·0 cites·20 claims
- 1561US2024390508A1Human transferrin receptor binding peptide-drug conjugateTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1660US12305169B2BBB-crossing lipid ligand of hetero nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted May 20, 2025·0 cites·28 claims
- 1753US2022370491A1Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
- 1852US2025333736A1Bbb-crossing lipid ligand of hetero nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2025·Application pending·0 cites
- 1948US2011301155A1Indazole compounds for activating glucokinaseYASUMA TSUNEO·Filed 2008·Application pending·0 cites
- 2045US11986480B2Heterocyclic compoundUNIV TOHOKU·Filed 2018·Granted May 21, 2024·0 cites·13 claims
- 2145US2007244169A1Glucokinase activatorsFENG JUN·Filed 2006·Application pending·0 cites
- 2244US10017508B2Nitrogenated heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 10, 2018·0 cites·11 claims
- 2344US2016159808A1Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2014·Application pending·0 cites
- 2437US9944596B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Apr 17, 2018·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Shigekazu Sasaki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →